Trilogy Capital’s iShares US Equity Factor ETF LRGF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-102,724
Closed -$4.33M – 170
2021
Q3
$4.33M Sell
102,724
-9,553
-9% -$418K 0.33% 54
2021
Q2
$4.89M Sell
112,277
-4,911
-4% -$208K 0.36% 52
2021
Q1
$4.76M Sell
117,188
-7,512
-6% -$295K 0.36% 53
2020
Q4
$4.7M Sell
124,700
-10,063
-7% -$358K 0.38% 51
2020
Q3
$4.47M Sell
134,763
-14,200
-10% -$466K 0.43% 48
2020
Q2
$4.81M Buy
148,963
+3,977
+3% +$118K 0.48% 52
2020
Q1
$4.24M Sell
144,986
-28,364
-16% -$914K 0.47% 50
2019
Q4
$5.98M Sell
173,350
-6,238
-3% -$207K 0.59% 44
2019
Q3
$5.66M Sell
179,588
-3,192
-2% -$101K 0.6% 46
2019
Q2
$5.88M Sell
182,780
-3,802
-2% -$119K 0.65% 41
2019
Q1
$5.79M Sell
186,582
-3,714
-2% -$112K 0.69% 40
2018
Q4
$5.3M Sell
190,296
-8,293
-4% -$255K 0.71% 32
2018
Q3
$6.68M Buy
198,589
+5,119
+3% +$171K 0.83% 29
2018
Q2
$6.18M Buy
193,470
+12,005
+7% +$387K 0.83% 29
2018
Q1
$5.72M Buy
181,465
+21,406
+13% +$692K 0.83% 29
2017
Q4
$5.09M Buy
+160,059
New +$4.99M 0.83% 28

Other funds holding LRGF

Trilogy Capital's LRGF Position: Q4 2021 in Review

Trilogy Capital sold out of iShares US Equity Factor ETF (LRGF) in Q4 2021, closing a stake of 102,724 shares — an estimated $4.33M sold.

Trilogy Capital first reported a position in LRGF in Q4 2017 and held it in 16 quarters. The position peaked at $6.68M in Q3 2018. 133 funds tracked by Wall St. Rank hold LRGF as of Q4 2021.

  • Trilogy Capital reported no remaining iShares US Equity Factor ETF position as of Q4 2021 after selling out during the quarter.
  • Trilogy Capital sold 102,724 iShares US Equity Factor ETF shares in Q4 2021, an estimated $4.33M.
  • Trilogy Capital first reported a position in iShares US Equity Factor ETF in Q4 2017 and held it in 16 quarters.
  • Trilogy Capital's iShares US Equity Factor ETF position peaked at $6.68M in Q3 2018.
  • 133 funds tracked by Wall St. Rank held iShares US Equity Factor ETF as of Q4 2021.

Based on Trilogy Capital's 13F filing for Q4 2021, filed 18 Jan 2022.